Overview
SCIEX offers LC-MS/MS systems, including Triple Quad and QTRAP models, for high-sensitivity analyte quantification and separation in pharmaceutical R&D and regulatory compliance testing. Their nominal mass spectrometers provide superior selectivity over HPLC, enabling faster sample throughput and accurate compound classification. Additional solutions include software and high-resolution mass spectrometry for drug screening and clinical diagnostics.
Frequently asked questions
- What LC-MS/MS capabilities does SCIEX provide for pharma R&D?
- SCIEX Triple Quad and QTRAP systems deliver high selectivity, sensitivity for MRM analysis, and QTRAP functionality for improved MS/MS confirmation and analyte separation from matrices.
- Are SCIEX systems compliant for regulated pharmaceutical testing?
- SCIEX LC-MS/MS systems support regulatory compliance with accurate quantification, qualifying components, and advantages over HPLC for reporting. Their clinical diagnostic portfolio is designated For In Vitro Diagnostic Use.
- What geographies does SCIEX serve for mass spectrometry solutions?
- SCIEX provides global mass spectrometry solutions including LC-MS, with products available internationally though not in all regions for certain clinical diagnostics.